Wolters Kluwer CEO Nancy McKinstry to retire in 2026, Stacey Caywood nominated successor

AMSTERDAM: Wolters Kluwer (Euronext: WKL) announced today that CEO and Chair of the Executive Board Nancy McKinstry will retire in February 2026 after a distinguished tenure.
The Supervisory Board will nominate Stacey Caywood, current CEO of Wolters Kluwer Health, as a member of the Executive Board at the Annual General Meeting of Shareholders on May 15, 2025. Caywood is expected to assume the CEO role in February 2026.
“On behalf of the entire Supervisory Board, I extend heartfelt congratulations to Nancy McKinstry on her well-deserved retirement next year,” said Ann Ziegler, Chair of the Supervisory Board.
“Nancy’s visionary leadership has been instrumental in driving Wolters Kluwer’s success, notably increasing the company’s market capitalization more than tenfold during her time as CEO. We are immensely grateful for the strong foundation she has built and her commitment to ensuring a seamless transition.”
“We are delighted to nominate Stacey Caywood as Wolters Kluwer CEO, effective February 2026,” Ziegler added.
“Stacey’s successful track record leading two of our largest divisions, her deep understanding of our business, and her active role in developing the group’s 2025-2027 strategic plan make her the ideal candidate. We have full confidence in her ability to continue Wolters Kluwer’s legacy of excellence and innovation.”
“It has been an honor and privilege to lead Wolters Kluwer through decades of transformation, and I am committed to ensuring the company’s continued strength and relevance,” said McKinstry.
“I am deeply grateful to the Board and my colleagues for their support. With Stacey as my successor, I am confident Wolters Kluwer will be in excellent hands.”
Stacey Caywood, who has led Wolters Kluwer Health since 2020, has overseen the evolution of the company’s healthcare solutions, ensuring professionals benefit from advanced clinical technology and evidence-based data. Previously, as CEO of Wolters Kluwer Legal & Regulatory, she led a strategic transformation across Europe and the U.S., driving the business back to organic growth.
Following the shareholders’ approval at the Annual General Meeting on May 15, 2025, the Executive Board of Wolters Kluwer N.V. will consist of Nancy McKinstry (CEO, until February 2026), Kevin Entricken (CFO), and Stacey Caywood.